Malaga Depression Burden Grows
2026-10-07
100,000 is not a marginal figure. It is the estimated number of Malaga province residents living with depression, while antidepressant sales through local pharmacies have risen 6.7 percent over the past year, turning a private illness into a public-health signal that cannot be dismissed as a statistical wobble. The shelves are speaking.
The prescription rise is meaningful, but it is not a clean census of suffering. Antidepressants, including selective serotonin reuptake inhibitors, are prescribed across different clinical courses; a filled prescription can reflect a new diagnosis, maintenance treatment, altered access to care, or a physician's changing practice. Depression is also hard to count, because prevalence estimates depend on screening, diagnosis, and whether patients seek help. Numbers matter. They also conceal.
Still, the direction is hard to shrug off. A 6.7 percent increase asks whether mental-health services are matching demand before medication becomes the default bridge over gaps in psychotherapy, follow-up, and social support. Pharmacotherapy can reduce symptoms; it cannot, by itself, repair isolation, insecurity, or delayed care. In a province measured by prescriptions, the quietest question remains: who is still unseen?
Loading...
